Publications (18) Publications in which a researcher has participated View referenced research data.

filter_list Internal Medicine

2025

  1. Economic assessment of abemaciclib for the adjuvant treatment of luminal HER2- breast cancer from the perspective of the Spanish health system

    European Journal of Health Economics, Vol. 26, Núm. 1, pp. 49-62

2023

  1. Cost-effectiveness of Diagnostic Tools to Establish the Presence of Peripheral Arterial Disease in People with Diabetes

    Annals of Surgery, Vol. 277, Núm. 1, pp. E184-E191

  2. Examining the benefit of graduated compression stockings in the prevention of hospital-associated venous thromboembolism in low-risk surgical patients: a multicentre cluster randomised controlled trial (PETS trial)

    BMJ open, Vol. 13, Núm. 1, pp. e069802

  3. The cost-effectiveness of a uniform versus age-based threshold for one-off screening for prevention of cardiovascular disease

    European Journal of Health Economics, Vol. 24, Núm. 7, pp. 1033-1045

2022

  1. Comparing methods for handling missing cost and quality of life data in the Early Endovenous Ablation in Venous Ulceration trial

    Cost Effectiveness and Resource Allocation, Vol. 20, Núm. 1

  2. Cost-effectiveness analysis of current varicose veins treatments

    Journal of Vascular Surgery: Venous and Lymphatic Disorders, Vol. 10, Núm. 2, pp. 504-513.e7

  3. “There is nothing better than participating in this study”: Living the PAPAartis cardiovascular randomised controlled trial

    Contemporary Clinical Trials Communications, Vol. 29

2020

  1. Economic evaluation of the introduction of 4CMenB (Bexsero®) in the national vaccine schedule in Spain

    Gaceta Sanitaria, Vol. 34, Núm. 4, pp. 318-325

  2. Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis

    Journal of Vascular Surgery: Venous and Lymphatic Disorders, Vol. 8, Núm. 1, pp. 8-23.e18

2019

  1. Cost-effectiveness analysis of a randomized clinical trial of early versus deferred endovenous ablation of superficial venous reflux in patients with venous ulceration

    British Journal of Surgery, Vol. 106, Núm. 5, pp. 555-562

  2. Cost-effectiveness of lenalidomide maintenance in patients with multiple myeloma who have undergone autologous transplant of hematopoietic progenitor cells

    Bone Marrow Transplantation, Vol. 54, Núm. 11, pp. 1908-1919

  3. Paraplegia prevention in aortic aneurysm repair by thoracoabdominal staging with 'minimally invasive staged segmental artery coil embolisation' (MIS2ACE): Trial protocol for a randomised controlled multicentre trial

    BMJ Open, Vol. 9, Núm. 3

2018

  1. Cost-Effectiveness of Current and Emerging Treatments of Varicose Veins

    Value in Health, Vol. 21, Núm. 8, pp. 911-920

  2. Differences in the economic valuation and determining factors of informal care over time: the case of blood cancer

    Gaceta Sanitaria, Vol. 32, Núm. 5, pp. 411-417

  3. Prevención primaria de enfermedades cardiovasculares: una revisión de revisiones de intervenciones no farmacológicas

    Anales del sistema sanitario de Navarra, Vol. 41, Núm. 3, pp. 355-369

  4. Systematic Review of the Effect of Adherence to Statin Treatment on Critical Cardiovascular Events and Mortality in Primary Prevention

    Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 23, Núm. 3, pp. 200-215

2015

  1. Productivity loss due to premature mortality caused by blood cancer: A study based on patients undergoing stem cell transplantation

    Gaceta Sanitaria, Vol. 29, Núm. 3, pp. 178-183

2008

  1. Factors associated with improvement in disability-adjusted life years in patients with HIV/AIDS

    BMC Public Health, Vol. 8